Cardiovascular disease - DiabetesontheNet

The final chapter in the rosiglitazone story

Rosiglitazone withdrawn: PCDS response

Managing diabetes in people with severe mental illness

Forget algorithms – treat all people with diabetes as being at high risk of CVD

Lowering blood pressure: Of any benefit in cardiovascular disease?

Diabetes – a coronary heart disease risk equivalent?

More clarity from ACCORD, or just more questions?

Cardiovascular risk: Managing hypertension in type 2 diabetes

CV risk factor control in type 2 diabetes – does ACCORD help?

Low-dose aspirin reduces CVD in people with type 2 diabetes

Does statin therapy increase the risk of type 2 diabetes?

Blood glucose at admission for acute myocardial infarction predicts future diabetes

New-onset diabetes and statin therapy

Adding up the evidence: Intensive glycaemic control and cardiovascular risk

Are different insulin formulations and regimens associated with different CV risk profiles?

Can improvements in primary care reduce diabetes-related hospitalisations?

New-onset diabetes and statin therapy

A randomised trial of therapies for type 2 diabetes and coronary artery disease: The BARI-2D study